Following its acquisition of Amedisys and LHC Group assets, BrightSpring Health Services (NASDAQ: BTSG) expects these new assets to drive a $30 million EBITDA boost in year one as they are integrated into the company’s platform.

The company continues to integrate the branches, which contributed $79 million in revenue and approximately $9 million in adjusted EBITDA in the first quarter, according to its Q1 earnings call on Friday.

“Provider [services] obviously had a bit of a tailwind from the closing of the home health branches,” John Rousseau, BrightSpring’s CEO, said on the earnings call. “But notwithstanding that, we saw really good growth. One of the reasons we had a little outperformance on the home health branches that were required was a step up in admissions.”

The company’s home health segment netted $266 million in revenue, a 49% increase year-over-year. Company leadership attributed the increase to strong census growth, de novo expansion, preferred Medicare Advantage contracts and the integration of newly acquired branches. Its Q1 home health average daily census rang in at 46,066.

BrightSpring is continuing to seek efficiencies and leverage AI tools. In home health, the company has centralized order intake across the Amedisys and LHC Group assets.

“They were not centralized, and we’re seeing some real benefit there already out of the gates,” Rousseau said.

Looking to future M&A, BrightSpring will continue with a disciplined approach, Rousseau said.

“We will continue to try to make sure we look at anything that makes the most sense in the long term. Across the organization, I think our bread and butter will continue to be geographical expansion, with tuck-ins in our current businesses that allow us to get into some new markets more quickly and where it makes sense, or where you need licensure, or CO, etc.,” Rousseau said. “I think deals in that mid-range or five to 10, are probably easier to do. But as we look at our pipeline right now, nothing too different than historically.”

While integrating the Amedisys and LHC Group assets, the company continues to make progress in crafting value-based care arrangements. It plans to apply to the Centers for Medicare and Medicaid Services’ (CMS) Long-term Enhanced ACO Design (LEAD) Model, for which applications are due in May.

Rousseau reported that the company was pleased with how Medicare home health and hospice rates have “shaken out” over the last six months. The Medicare home health base rate for 2026 was finalized with a 1.3%, or $220 million, compared to calendar year 2025. The 1.3% cut is significantly lower than the 6.4% aggregate reduction CMS originally proposed.

In its personal care segment, BrightSpring reported Q1 revenue of $102 million, representing 4% year-over-year growth. Leadership attributed the increase to modest growth in persons served and stable operations. The company served 16,079 people in its personal care segment in Q1.

Overall, BrightSpring reported Q1 net revenues of $3,614 million, a 25.6% increase year-over-year.

The post BrightSpring’s Amedysis, LHC Acquisition Drove $79M In Q1 Revenue  appeared first on Home Health Care News.